{"organizations": [], "uuid": "defc579d89c27a03f5df12ecc334c07b7b2da795", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources/r/?m=02&d=20180425&t=2&i=1255028564&w=1200&r=LYNXMPEE3O00S", "site_section": "https://www.reuters.com/", "section_title": "Business &amp; Financial News, U.S &amp; International Breaking News | Reuters", "url": "https://www.reuters.com/article/us-shire-takeda-pharma-stocks/takeda-shares-slide-5-percent-after-revised-proposal-for-shire-idUSKBN1HW011", "country": "US", "domain_rank": 408, "title": "Takeda shares slide 5 percent after revised proposal for Shire", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T08:20:00.000+03:00", "replies_count": 0, "uuid": "defc579d89c27a03f5df12ecc334c07b7b2da795"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/us-shire-takeda-pharma-stocks/takeda-shares-slide-5-percent-after-revised-proposal-for-shire-idUSKBN1HW011", "ord_in_thread": 0, "title": "Takeda shares slide 5 percent after revised proposal for Shire", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "none"}, {"name": "eric meijer", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "chris gallagher", "sentiment": "none"}], "locations": [{"name": "glattbrugg", "sentiment": "none"}, {"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "takeda pharmaceutical co", "sentiment": "negative"}, {"name": "shire tokyo", "sentiment": "negative"}, {"name": "takeda", "sentiment": "negative"}, {"name": "shire plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "TOKYO (Reuters) - Takeda Pharmaceutical Co shares fell more than 5 percent in early trade on Wednesday following news it had sweetened its acquisition offer for London-listed drugmaker Shire Plc to 46 billion pounds ($64 billion).\nLogos of Japanese Takeda Pharmaceutical Co are seen at an office building in Glattbrugg near Zurich March 7, 2012. REUTERS/Arnd Wiegmann/File Photo /File Photo Shire said in a statement it was willing to recommend to its shareholders a deal with the Japanese pharmaceutical company. It said it had agreed to extend a Wednesday regulatory deadline for the deal talks until May 8 in order to allow Takeda to carry out more due diligence and firm up its bid.\nReporting by Chris Gallagher; Editing by Eric Meijer\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T08:20:00.000+03:00", "crawled": "2018-04-25T03:58:58.022+03:00", "highlightTitle": ""}